Kai-Uwe Eckardt

Epidemiology · 2003–2020

A researcher in the Science corpus: 20 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 32 citations into it
• Hepatology — 11 citations into it

Whom Kai-Uwe Eckardt trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. A. Levey
2. Alan S. Go
3. Josef Coresh

Who trusts Kai-Uwe Eckardt overall

1. A. Levey
2. Josef Coresh

Papers from Kai-Uwe Eckardt's perspective

Ordered by how strongly the researchers Kai-Uwe Eckardt trusts endorse each paper. Same corpus, a different order for every researcher.

1. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
2. The support of human genetic evidence for approved drug indications (Nature Genetics)
3. Prevalence of chronic kidney disease in the United States. (Journal of the American Medical Association (JAMA))
4. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). (Kidney International)
5. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (Kidney International)
6. Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
7. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
8. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
9. Guidelines for investigating causality of sequence variants in human disease
10. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. (The Lancet)

Their papers

• Differentiating the functional role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α (EPAS‐1) by the use of RNA interference: erythropoietin is a HIF‐2α target gene in Hep3B and Kelly cells (2004) — 391 citations
• Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. (2020) — 632 citations
• A catalog of genetic loci associated with kidney function from analyses of a million individuals (2019) — 744 citations
• Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage (2018) — 654 citations
• Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. (2017) — 787 citations
• Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes (2017) — 401 citations
• Evolving importance of kidney disease: from subspecialty to global health burden. (2013) — 1,091 citations
• KDIGO Clinical Practice Guideline for Glomerulonephritis (2012) — 897 citations
• Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (2011) — 922 citations
• The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (2011) — 2,281 citations
• Association of estimated glomerular filtration rate and albuminuria with mortality and end-stage renal disease: a collaborative meta-analysis of kidney disease cohorts (2011) — 750 citations
• Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011) — 1,030 citations
• Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C–dependent buffering mechanism (2009) — 929 citations
• A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. (2009) — 1,130 citations
• Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. (2007) — 982 citations
• Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. (2007) — 1,516 citations
• Normalization of hemoglobin level in patients with chronic kidney disease and anemia. (2006) — 2,125 citations
• Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). (2005) — 3,883 citations
• Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. (2004) — 886 citations
• Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. (2003) — 814 citations